• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CHIN to accelerate development of new vaccines and therapies

CHIN to accelerate development of new vaccines and therapies

December 15, 2011
CenterWatch Staff

Seven universities, led by The University of Western Ontario, have been awarded a $600,000 catalyst grant from the Canadian Institutes of Health Research (CIHR) to create a national network to promote and enhance research on the body’s immune system. 

The CIHR Human Immunology Network (CHIN) will facilitate basic and clinical research and will help position Canada as a leader in the development of new vaccines and therapies for infectious diseases, allergies, HIV/AIDS, cancer, and transplantation.

Western will be joined by McGill, McMaster, the University of Toronto, the University of British Columbia, the University of Manitoba, and Dalhousie University. The Centre for Human Immunology at Western’s Schulich School of Medicine & Dentistry is the coordinating center.

"CHIN will position Canada as a world leader in human immunology and its translation to improve global health,” says CHIN principle investigator and executive director Quim Madrenas, chair of the department of microbiology and immunology at McGill. “From developing vaccines to discovering new therapies to treat autoimmune diseases and transplant rejection, from improving food and water safety to preparedness for emerging infections, CHIN will be an invaluable resource to the community.”

CHIN will act as a coordinating resource for investigators working in different aspects of the immune system to ensure that human immunology in Canada remains at the forefront of the international effort.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing